Citation Impact
Citing Papers
The Basic Principles of Chimeric Antigen Receptor Design
2013
Designed protein logic to target cells with precise combinations of surface antigens
2020 StandoutScienceNobel
High level PSMA expression is associated with early psa recurrence in surgically treated prostate cancer
2010
The management of heparin‐induced thrombocytopenia
2006
Heparin-induced thrombocytopenia (HIT)
2006
Self-adjuvanted mRNA vaccination in advanced prostate cancer patients: a first-in-man phase I/IIa study
2015
Cutaneous Wound Healing
1999 Standout
Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma
1998
Mechanisms of Thrombus Formation
2008 Standout
Rapid Healing of Venous Ulcers and Lack of Clinical Rejection With an Allogeneic Cultured Human Skin Equivalent
1998
Regulation of endothelium-derived nitric oxide production by the protein kinase Akt
1999 StandoutNature
A Clinical Trial of Vena Caval Filters in the Prevention of Pulmonary Embolism in Patients with Proximal Deep-Vein Thrombosis
1998 Standout
Cerebrovascular complications in Ehlers‐Danlos syndrome type IV
1995
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Laboratory Testing for Heparin-Induced Thrombocytopenia
2000
Prostate-specific membrane antigen expression is greatest in prostate adenocarcinoma and lymph node metastases
1998
Clinical and Genetic Features of Ehlers–Danlos Syndrome Type IV, the Vascular Type
2000 Standout
Paraneoplastic Syndromes Involving the Nervous System
2003 Standout
The Greenfield Vena Cava Filter
1988
Renal-Artery Stenosis
2001 Standout
Diagnostic and therapeutic strategies of white clot syndrome
1991
The Protective Effects of Estrogen on the Cardiovascular System
1999 Standout
Heparin-induced thrombocytopenia with thrombosis: Incidence, analysis of risk factors, and clinical outcomes in 108 consecutive patients treated at a single institution
1997
68Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0
2017
Heparin-Induced Thrombocytopenia
1998
Multidetector Computed Tomography for Acute Pulmonary Embolism
2006 Standout
Targeting novel antigens for prostate cancer treatment: focus on prostate-specific membrane antigen
2005
Argatroban Anticoagulation in Patients With Heparin-Induced Thrombocytopenia
2003
Subcutaneous Low-Molecular-Weight Heparin Compared with Continuous Intravenous Heparin in the Treatment of Proximal-Vein Thrombosis
1992 Standout
Temporal Aspects of Heparin-Induced Thrombocytopenia
2001 Standout
Failure of early heparin cessation as treatment for heparin-induced thrombocytopenia
1999
Guideline for Prevention of Intravascular-Device–Related Infections
1996
Guideline for Prevention of Intravascular-Device-Related Infections
1996
Specific binding of vascular permeability factor to endothelial cells
1991
Obstetrical problems in patients with Ehlers-Danlos syndrome type IV; a case report
1989
Dynamic activation of endothelial nitric oxide synthase by Hsp90
1998 Nature
Heparin-Induced Thrombocytopenia
2006 Standout
The Clinical Course of Pulmonary Embolism
1992 Standout
A Prospective Study of Venous Thromboembolism after Major Trauma
1994 Standout
Balloon aortic valvuloplasty: Results of the Valvuloplasty and Angioplasty of Congenital Anomalies Registry
1990
Heparin-Induced Skin Lesions and Other Unusual Sequelae of the Heparin-Induced Thrombocytopenia Syndrome
2005
Percutaneous Balloon Valvuloplasty
1990
Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated Heparin
1995 Standout
Immunotherapy for prostate cancer
2006
Heparin‐induced thrombocytopenia and thrombosis: clinical and laboratory studies
1993
Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes
2002 Standout
Combinatorial antigen recognition with balanced signaling promotes selective tumor eradication by engineered T cells
2012
A 14-year study of heparin-induced thrombocytopenia
1996 Standout
Severe Adverse Cutaneous Reactions to Drugs
1994 Standout
Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
2005 Standout
Endoluminal Stent–Grafts for Infrarenal Abdominal Aortic Aneurysms
1997 Standout
Antithrombotic Therapy in Neonates and Children
2008
[177Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study
2018
Translational activation of the lck proto-oncogene
1988 StandoutNatureNobel
The Pathophysiology of Heparin-Induced Thrombocytopenia
2005
Disseminated Intravascular Coagulation
1999 Standout
The Golgi Association of Endothelial Nitric Oxide Synthase Is Necessary for the Efficient Synthesis of Nitric Oxide
1995
The Theranostic PSMA Ligand PSMA-617 in the Diagnosis of Prostate Cancer by PET/CT: Biodistribution in Humans, Radiation Dosimetry, and First Evaluation of Tumor Lesions
2015
Spontaneous Dissection of the Carotid and Vertebral Arteries
2001 Standout
Therapeutic T cell engineering
2017 Nature
Tantalum-Dacron coknit stent for endovascular treatment of aortic aneurysms: A preliminary experimental study
1994
Diagnosis and treatment of diseases of the aorta
1997
Sequences of the 5′ portion of the humanc-sisgene: characterization of the transcriptional promoter and regulation of expression of the protein product by 5' untranslated mRNA sequences
1987
Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule
1984 StandoutNature
gamma and alpha chains of human fibrinogen possess sites reactive with human platelet receptors.
1982
Selection and characterization of bovine aortic endothelial cells
1978
Characterization and fibrinolytic properties of human omental tissue mesothelial cells. Comparison with endothelial cells
1990 Standout
Serpin Structure, Mechanism, and Function
2002 Standout
SPAS-1 (stimulator of prostatic adenocarcinoma-specific T cells)/SH3GLB2: A prostate tumor antigen identified by CTLA-4 blockade
2008 StandoutNobel
Sequence determination of the thiolester site of the fourth component of human complement.
1981
Diagnostic Value of Ventilation-Perfusion Lung Scanning in Patients with Suspected Pulmonary Embolism
1985
Detection and characterisation of an overmodified type III collagen by analysis of non-cutaneous connective tissues in a patient with Ehlers-Danlos syndrome IV.
1992
White Clot Syndrome
1979
Adoptive cell transfer as personalized immunotherapy for human cancer
2015 StandoutScience
Preventing Complications of Central Venous Catheterization
2003 Standout
Neurovascular manifestations of heritable connective tissue disorders. A review.
1994
Anticoagulation Monitoring during Cardiac Surgery
1999
Rapid anticoagulation using ancrod for heparin-induced thrombocytopenia [see comments]
1991
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Aggregation-Induced Emission: Together We Shine, United We Soar!
2015 Standout
Greenfield Vena Caval Filter Experience
1981
Indications for Cardiac Catheterization and Intervention in Pediatric Cardiac Disease
2011 Standout
Delayed-Onset Heparin-Induced Thrombocytopenia
2002
Short- and long-term interactions of endothelium and vascular smooth muscle in coculture: effects on cyclic GMP production.
1986
Effect of Heparin and Heparin Fractions on Platelet Aggregation
1980
Heparin-induced thrombocytopenia: laboratory studies
1988
The covalent nature of the human antithrombin III–thrombin bond
1980
Heparin‐induced thrombocytopenia: Association with a platelet aggregating factor and arterial thromboses
1979
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
The fms -Like Tyrosine Kinase, a Receptor for Vascular Endothelial Growth Factor
1992 StandoutScience
Different platelet specificities of heparin‐dependent platelet aggregating factors in heparin‐associated immune thrombocytopenia
1986
Phase III Study Comparing Three Cycles of Infusional Carmustine and Cisplatin Followed by Radiation Therapy With Radiation Therapy and Concurrent Carmustine in Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme: Eastern Cooperative Oncology Group Trial 2394
2003
Successful revascularization of an occluded renal artery after prolonged anuria
1989
Surgical management of aneurysms of the distal extracranial internal carotid artery
1986
Chimeric Antigen Receptor Therapy
2018 Standout
Large kindred with Ehlers-Danlos syndrome type IV due to a point mutation (G571S) in theCOL3A1 gene of type III procollagen: Low risk of pregnancy complications and unexpected longevity in some affected relatives
1999
Potent Antitumor Activity of an Auristatin-Conjugated, Fully Human Monoclonal Antibody to Prostate-Specific Membrane Antigen
2006
Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer
2021 Standout
COAGULATION DISORDERS IN CANCER
1996
Thrombotic Complications of Heparin Therapy Including Six Cases of Heparin-Induced Skin Necrosis
1979
Reversible Acute Renal Failure as an Atypical Presentation of Ischemic Nephropathy
1993
Impact of Natural Products on Developing New Anti-Cancer Agents
2009 Standout
Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination
2021 Standout
Low-Molecular-Weight Heparins
1997 Standout
Ischemic renal disease: An overlooked clinical entity?
1988
Management of Deep Vein Thrombosis and Pulmonary Embolism
1996
Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide.
1987 Standout
Platelet factor 4 binds to low-density lipoprotein receptors and disrupts the endocytic itinerary, resulting in retention of low-density lipoprotein on the cell surface
2002 StandoutNobel
Relative proteolysis of the fibrinogen Bβ chain by thrombin and plasmin as a determinant of thrombosis
1981 Nature
Heparin-Associated Thrombocytopenia
1984
The incidence of heparin-induced thrombocytopenia in hospitalized medical patients treated with subcutaneous unfractionated heparin: a prospective cohort study
2003
Paradoxical Vasoconstriction Induced by Acetylcholine in Atherosclerotic Coronary Arteries
1986 Standout
Antibodies to Macromolecular Platelet Factor 4-Heparin Complexes in Heparin-induced Thrombocytopenia: a Study of 44 Cases
1995
Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination
2021 Standout
CAR T cell immunotherapy for human cancer
2018 StandoutScience
Argatroban Anticoagulant Therapy in Patients With Heparin-Induced Thrombocytopenia
2001 Standout
Isolation of cDNA clones specifying the fourth component of mouse complement and its isotype, sex-limited protein.
1984 StandoutNobel
Revascularization to Preserve Renal Function in Patients with Atherosclerotic Renovascular Disease
1984
Immune Endothelial-Cell Injury in Heparin-Associated Thrombocytopenia
1987
The role of fragment X polymers in the fibrin enhancement of tissue plasminogen activator-catalyzed plasmin formation.
1990 StandoutNobel
Heparin-associated thrombocytopenia and thrombosis: A serious clinical problem and potential solution
1986
Works of Donald Silver being referenced
Can low molecular weight heparins and heparinoids be safely given to patients with heparin-induced thrombocytopenia syndrome?
1993
Preirradiation Chemotherapy of Supratentorial Malignant Primary Brain Tumors with Intracarotid cis-Platinum (CDDP) and i.v. BCNU
1990
Heparin-induced thrombocytopenia in open heart surgical patients: Sequelae of late recognition
1992
Reduced morbidity and mortality rates of the heparin-induced thrombocytopenia syndrome
1998
Use of enoxaparin in patients with heparin-induced thrombocytopenia syndrome
1996
Reexposure to heparin of patients with heparin-associated antibodies
1989
Is thrombosis of the infrarenal abdominal aortic aneurysm an acceptable alternative?
1986
Reexposure to heparin of patients with heparin-associated antibodies
1989
Heparin-coated catheters and heparin-induced thrombocytopenia
1988
Extracorporeal Circulation in a Patient with Heparin-induced Thrombocytopenia
1985
Heparin-induced thrombocytopenia, thrombosis, and hemorrhage.
1979
In VivoDemonstration of Small-Airway Bronchoconstriction Following Pulmonary Embolism
1973
Heparin-lnduced Thrombocytopenia, Thrombosis, and Hemorrhage
1983
Assessment of percutaneous balloon pulmonary and aortic valvuloplasty
1984
Spontaneous arterial perforation: The Ehlers-Danlos specter
1987
Heparin induced thrombocytopenia with thrombotic and hemorrhagic manifestations.
1973
Successful Surgical Treatment of Anuria Caused by Renal Artery Occlusion
1982
Is thrombosis of the infrarenal abdominal aortic aneurysm an acceptable alternative?
1986
Heparin Induced Thrombocytopenia
1977
Populations with the Leriche syndrome.
1981
Heparin-induced thrombocytopenia in the newborn
1992
The role of vena caval interruption in the management of pulmonary embolism.
1975
Serosal hypofibrinolysis
1973
The heparin-induced thrombocytopenia syndrome: an update.
1987
Prostate-specific membrane antigen expression in normal and malignant human tissues.
1997
Progress in Hemostasis and Thrombosis
1977
Surgical management of refractory venous stasis ulceration
1988
Congenital Aneurysm of the Extracranial Carotid Arteries
1972